August 18, 2025

FDA Approves New Indication for Wegovy

Accelerated approval granted to Wegovy for treatment of noncirrhotic metabolic dysfunction–associated steatohepatitis in adults with stage F2 to F3 fibrosis.

Conexiant

August 18, 2025

Societies Issue Joint Updates to Hypertension Guidelines

A central update is the recommendation for use of the PREVENT calculator to help determine risk.

Conexiant

August 15, 2025

Studies Explore Cardiac Risks and Clinical Characteristics Associated With Immune Checkpoint Inhibitor–Related Myocarditis

Immune checkpoint inhibitors (ICIs) have significantly impacted treatment options for a wide range of cancers given their efficacy, especially among cancer types that are considered immunologically “h...

The ASCO Post

August 14, 2025

Greater Variety of Flavonoids Tied to Lower Chronic Disease

Higher diversity and quantity of dietary flavonoid intake were each linked to reduced risks of mortality and major chronic diseases in a large population-based study.

Conexiant

August 11, 2025

FDA OKs Bioequivalent Iron Sucrose for CKD Anemia

The FDA has approved a bioequivalent iron sucrose injection for treating iron deficiency anemia in patients with chronic kidney disease.

Conexiant

August 07, 2025

Every 1,000 Steps May Slash Heart Risk 17%

Each additional 1,000 daily steps a day may be associated with a reduction in major adverse cardiovascular events among patients with hypertension, with benefits evident at step counts well below 10,000 steps per day.

Conexiant

August 07, 2025

Delayed Hypertension Diagnoses Raise 5-Year Cardiovascular Risk

Analysis of electronic health records reveals that delays in clinical hypertension diagnosis persist despite frequent outpatient visits and are linked to increased cardiovascular event rates.

Conexiant

August 07, 2025

Study Ties Asthma to Cardiometabolic Risk

Researchers studying nearly 29,000 middle-aged adults in Sweden found that individuals with asthma had significantly higher rates of hypertension, diabetes, and other conditions, along with elevated levels of systemic inflammation and blood sugar markers.

Conexiant

August 06, 2025

DASH4D: Sodium Reduction Lowered Blood Pressure in T2D

Researchers found that a lower sodium DASH-style diet tailored for type 2 diabetes reduced blood pressure in adults receiving antihypertensive treatment.

Conexiant